Search Results 871-880 of 21558 for Inhibition
Viokace™ tablet is used in combination with certain medicines for stomach ulcer called proton pump inhibitors (eg, esomeprazole, lansoprazole, omeprazole, ...
No daily use of phosphodiesterase 5 (PDE5) inhibitors ... Ongoing requirement for PDE5 inhibitor, organic nitrate or soluble guanylyl cyclase activators.
Chronic concomitant treatment with strong inhibitors or inducers of CYP3A4 is not allowed on this study. Patients on strong inhibitors or inducers of CYP3A4 ...
Like ACE inhibitors, angiotensin II receptor blockers often are useful for people with coronary artery disease, heart failure or kidney failure. These ...
Serotonin and norepinephrine reuptake inhibitors (SNRIs). Some SNRIs can be treatment options during pregnancy. · Bupropion (Forfivo XL, Wellbutrin SR). Most ...
... inhibitors are allowed, but must have been a constant dose for ≥ 4 weeks and must not be expected to stop the medication during the study period).
Kenderian's laboratory is testing the optimal development of combinatorial approaches with signal inhibitors, small molecule approach and other ...
... inhibitor [TKI]; Cohort D and MET-2: platinum-based chemotherapy) for metastatic disease, or be ineligible for, or have refused all other currently ...
... inhibitor. Patients may not have received the following within 7 days prior to the first dose of study drug: Strong and moderate CYP3A inhibitors;; Strong ...
... inhibitors, BCL-2 inhibitors and other approved anti-CLL /SLL therapies/regimens. This study also evaluates association of treatment patterns with ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.